Author

Ke Zhong

Sun Yat-sen UniversityORCID 0009-0004-5519-628XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Ke Zhong1 paper · Third Affiliated Hospital of Guangzhou Medical University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Cheng YiiD· 1 shared Haisheng ZhangiD· 1 shared Hongsheng WangiD· 1 shared Hongxin Niu· 1 shared Jiawang Zhou· 1 shared Jiaxin He· 1 shared Lijun Tao· 1 shared Xiansong Wang· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Cheng YiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyResearchPeer-reviewedJan 1, 2026

METTL3 inhibition-activated cGAS/STING axis enhances immunotherapy and PARP inhibitor sensitivity of lung carcinoma

Jiawang Zhou, Jiaxin He, Yunqing Lu…·Hongsheng Wang

This study shows that inhibiting METTL3 activates the cGAS/STING pathway, enhancing anti-tumor immunity and PARP inhibitor sensitivity in lung carcinoma.

1 citation

humanDNA methylation